Corebridge Financial Inc. cut its stake in Danaher Co. (NYSE:DHR – Free Report) by 4.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 165,066 shares of the conglomerate’s stock after selling 7,065 shares during the period. Corebridge Financial Inc.’s holdings in Danaher were worth $37,891,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of the company. Heck Capital Advisors LLC bought a new stake in Danaher in the 4th quarter valued at about $27,000. Decker Retirement Planning Inc. bought a new position in Danaher in the 4th quarter worth about $31,000. Golden State Wealth Management LLC acquired a new stake in shares of Danaher in the fourth quarter valued at approximately $31,000. Strategic Financial Concepts LLC bought a new stake in shares of Danaher during the fourth quarter valued at approximately $31,000. Finally, Pineridge Advisors LLC boosted its position in shares of Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after buying an additional 57 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.
Insider Activity at Danaher
In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 11.10% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
Read Our Latest Report on Danaher
Danaher Price Performance
NYSE DHR opened at $211.63 on Monday. Danaher Co. has a 1 year low of $196.80 and a 1 year high of $281.70. The stock’s 50-day moving average price is $217.46 and its two-hundred day moving average price is $238.50. The company has a market cap of $151.26 billion, a PE ratio of 40.08, a PEG ratio of 2.66 and a beta of 0.82. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the company earned $2.09 EPS. On average, analysts predict that Danaher Co. will post 7.63 EPS for the current year.
Danaher Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.60%. The ex-dividend date of this dividend is Friday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio (DPR) is 24.24%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- How to start investing in penny stocks
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- Most Volatile Stocks, What Investors Need to Know
- 3 ETFs to Ride the VIX Surge During Market Volatility
- How to Invest in Insurance Companies: A GuideĀ
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.